HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.

Abstract
The CD5 antigen is a T-cell associated marker that is also usually expressed by two B-cell neoplasms, chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma. We observed CD5 antigen expression in a subset of cases of intravascular large B-cell lymphoma (IVLBL), and we report here five cases. The patients, two men and three women, ranged in age from 59 to 81 years. Biopsy specimens were obtained from kidney, lung, bone marrow, abdominal wall, and neck, the latter involving a lymphangioma. All of the cases had histologic features typical of IVLBL, with large and atypical lymphoid cells located predominantly within blood vessels. Immunohistochemical studies performed using routinely fixed, paraffin-embedded tissue sections showed that the neoplastic cells were B cells, positive for the CD20 antigen and negative for the CD3 or CD43 antigens. All cases were also positive for the CD5 antigen. One case had an immunoglobulin heavy chain gene rearrangement shown by using a polymerase chain reaction method. The finding of CD5 antigen expression in a subset of IVLBL cases adds to other evidence in the literature suggesting that IVLBL is a heterogeneous entity. We considered the possibility that these cases were related to or represented unusual histologic forms of transformation from either chronic lymphocytic leukemia/small lymphocytic lymphoma or mantle cell lymphoma. All of the cases, however, were negative for the CD23 antigen and cyclin D1 (bcl-1) protein, which is evidence against this interpretation. The biologic significance of CD5 antigen expression in cases of IVLBL is uncertain. These neoplasms might arise from a separate lineage of CD5-positive B cells or from a specific, early stage of B-cell differentiation. Alternatively, some investigators have suggested that CD5 antigen expression by B cells is a marker of activation.
AuthorsH S Khalidi, R K Brynes, P Browne, C H Koo, H Battifora, L J Medeiros
JournalModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (Mod Pathol) Vol. 11 Issue 10 Pg. 983-8 (Oct 1998) ISSN: 0893-3952 [Print] United States
PMID9796727 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD20
  • Biomarkers, Tumor
  • CD5 Antigens
  • DNA Primers
Topics
  • Aged
  • Aged, 80 and over
  • Antigens, CD20 (metabolism)
  • Biomarkers, Tumor (metabolism)
  • Bone Marrow Neoplasms (metabolism, pathology)
  • CD5 Antigens (metabolism)
  • DNA Primers (chemistry)
  • Female
  • Head and Neck Neoplasms (metabolism, pathology)
  • Hemangioendothelioma (metabolism, pathology)
  • Humans
  • Immunoenzyme Techniques
  • Kidney Neoplasms (metabolism, pathology)
  • Lung Neoplasms (metabolism, pathology)
  • Lymphangioma (metabolism, pathology)
  • Lymphoma, B-Cell (metabolism, pathology)
  • Lymphoma, Large B-Cell, Diffuse (metabolism, pathology)
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Skin Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: